
Bayesian analysis of 6,082-patient PARAMEDIC-3 trial calculates 82% posterior probability of inferior survival with initial intraosseous vs intravenous access in cardiac arrest
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A Bayesian secondary analysis of the 6,082-patient PARAMEDIC-3 trial calculated an 81.6% posterior probability that an intraosseous-first access strategy was inferior to intravenous-first access for 30-day survival in out-of-hospital cardiac arrest.
What NurseJet pulled from the source
Securing rapid vascular access for resuscitation drug delivery is critical in cardiac arrest, but the relative clinical efficacy of intraosseous (IO) versus intravenous (IV) cannulation remains debated. Investigators conducted a pre-planned Bayesian secondary analysis of the multicenter PARAMEDIC-3 randomized trial (ISRCTN14223494), in which 6,082 adults experiencing non-traumatic out-of-hospital cardiac arrest were randomized to an initial IO-first or IV-first vascular access strategy. Using non-informative priors adjusted for baseline covariates, the posterior probability that IO-first access improved 30-day survival (odds ratio [OR] > 1.0) was only 18.4%, corresponding to an 81.6% probability that IO-first access was inferior (OR < 1.0). The probability of a small disadvantage (OR < 0.9) was 55.0%, and moderate disadvantage (OR < 0.75) was 13.4%. Similar patterns emerged for favorable neurological outcome, while for return of spontaneous circulation (ROSC) at hospital handover, the probability of IO inferiority was 98.0%.
Why this matters for nurses
Emergency and trauma nurses frequently manage vascular access during cardiac arrests in the emergency department and resuscitation bays. While IO devices provide rapid and reliable placement during difficult access, these Bayesian findings reinforce that intravenous administration delivers superior pharmacokinetics and resuscitation outcomes, supporting intravenous attempts as primary whenever readily achievable.
Bedside takeaway
In a Bayesian analysis of the 6,082-patient PARAMEDIC-3 trial, initial intraosseous access had an 81.6% posterior probability of inferior 30-day survival and 98.0% probability of inferior ROSC compared with initial intravenous access in cardiac arrest.
Key takeaways
- Pre-planned Bayesian secondary analysis of the PARAMEDIC-3 trial evaluated 6,082 adult out-of-hospital cardiac arrest patients.
- Posterior probability that an IO-first approach improved 30-day survival was only 18.4%, with an 81.6% probability of inferiority compared with IV-first.
- The probability that IO-first was inferior for return of spontaneous circulation (ROSC) at hospital handover was 98.0%.
- Findings indicate that while intraosseous access is vital when IV access cannot be obtained, initial intravenous access remains clinically preferred for drug efficacy.
Practice implications
- Prioritize rapid intravenous cannulation attempts for resuscitation pharmacotherapy during cardiac arrest per ACLS protocols; deploy intraosseous access without delay when peripheral IV attempts fail or are clinically unfeasible.
Limitations & cautions
- Secondary analysis of trial data subject to protocolized prehospital paramedic workflows; primary analysis modeled non-informative priors; exact drug delivery transit times were not directly measured.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Resuscitation (PubMed)
Resuscitation (PubMed). Intraosseous versus intravenous access in adult out-of-hospital cardiac arrest: a Bayesian secondary analysis of the PARAMEDIC-3 randomised controlled trial.
https://pubmed.ncbi.nlm.nih.gov/42790855/
Professional education only


